Vimarsana
Biggest News Aggregation in the World

Catherinet Doherty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Catherinet Doherty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Catherinet Doherty Today - Breaking & Trending Today

Quest Diagnostics (NYSE:DGX) Rating Increased to Buy at StockNews.com - Vimarsana News

Quest Diagnostics (NYSE:DGX) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a hold rating to a buy rating in a report issued on Friday. DGX has been the topic of several other reports. Citigroup upped their price target on Quest Diagnostics from $135.00 to $145.00 and gave the company a neutral rating in a research […]

Philadelphia Trust Co. Decreases Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - Vimarsana News

Philadelphia Trust Co. Decreases Holdings in Quest Diagnostics Incorporated (NYSE:DGX)

Philadelphia Trust Co. reduced its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 17.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,329 shares of the medical research company’s stock after selling 945 shares during the period. Philadelphia Trust Co.’s […]

Quest Diagnostics (NYSE:DGX) Rating Lowered to Hold at StockNews.com - Vimarsana News

Quest Diagnostics (NYSE:DGX) Rating Lowered to Hold at StockNews.com

StockNews.com cut shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a research report released on Friday morning. DGX has been the subject of a number of other research reports. Barclays lifted their price target on shares of Quest Diagnostics from $138.00 to $144.00 and gave the […]

Citigroup Increases Quest Diagnostics (NYSE:DGX) Price Target to $145.00 - Vimarsana News

Citigroup Increases Quest Diagnostics (NYSE:DGX) Price Target to $145.00

Quest Diagnostics (NYSE:DGX – Free Report) had its target price upped by Citigroup from $135.00 to $145.00 in a report released on Wednesday, Benzinga reports. The firm currently has a neutral rating on the medical research company’s stock. Other research analysts have also recently issued research reports about the stock. SVB Leerink initiated coverage on […]

Yousif Capital Management LLC Reduces Position in Quest Diagnostics Incorporated (NYSE:DGX) - Vimarsana News

Yousif Capital Management LLC Reduces Position in Quest Diagnostics Incorporated (NYSE:DGX)

Yousif Capital Management LLC decreased its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 4.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,102 shares of the medical research company’s stock after selling 1,236 shares during the […]